VarCov Co’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
VarCov Co's MDGL Position: Q3 2026 in Review
VarCov Co sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 1,018 shares — an estimated $547K sold.
VarCov Co first reported a position in MDGL in Q2 2026 and held it in 1 quarter. The position peaked at $547K in Q2 2026. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- VarCov Co reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- VarCov Co sold 1,018 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $547K.
- VarCov Co first reported a position in Madrigal Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- VarCov Co's Madrigal Pharmaceuticals position peaked at $547K in Q2 2026.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.